Waystar Holding Corp. WAY
Deals with insiders in the proxy filed Apr 17, 2026
Proxy, Item 404Deals between WAY and its directors, executives, owners of more than 5% or their families: a relative on the payroll, a plane the company charters from its CEO, a director's company that buys from it. SEC rules (Item 404) make the company list every such deal over $120,000 in its proxy statement.
New this year
Compared with Apr 29, 2025
Paragraphs about a deal, a person or a relative with nothing like them in the proxy filed Apr 29, 2025.
Other Related Party Transactions“+Aveanna Healthcare, LLC, Surgery Partners Holdings LLC, Athena Therapy, US Renal Care, AccentCare, and Definitive Healthcare are our clients to whom we provide software solutions. Bain beneficially owns greater than 10% of each of Aveanna Healthcare, LLC, Surgery Partners Holdings LLC, Athena Therapy, and US Renal Care. We received approximately $0.4 million from Aveanna Healthcare, LLC for the year ended December 31, 2025. We received approximately $1.3 million from Surgery Partners Holdings LLC for the year ended December 31, 2025. We received approximately $0.1 million from Athena Therapy for the year ended December 31, 2025. We received approximately $0.8 million from US Renal Care for the year ended December 31, 2025. After the Iodine acquisition on October 1, 2025, Advent has an ownership interest in us and beneficially owns greater than 10% of AccentCare and Definitive Healthcare. We received approximately $0.4 million from AccentCare for the year ended December 31, 2025 subsequent to the Iodine acquisition. We received approximately $0.4 million from Definitive Healthcare for the year ended December 31, 2025 subsequent to the Iodine acquisition.”
Read it in the proxyopen_in_new
Other Related Party Transactions“+Rocket Software, Fidelity Information Services, CitrusTech, and Definitive Healthcare are vendors that provide us with software solutions. Bain beneficially owns greater than 10% of each of Rocket Software, Fidelity Information Services, and Citrus Tech. We paid approximately $0.4 million to Rocket Software for the year ended December 31, 2025. We paid approximately $1.9 million to Fidelity Information Services for the year ended December 31, 2025. We paid approximately $0.3 million to Citrus Tech for the year ended December 31, 2025. After the Iodine acquisition on October 1, 2025, Advent has an ownership interest in us and beneficially owns greater than 10% of Definitive Healthcare. We paid approximately $0.1 million to Definitive Healthcare for the year ended December 31, 2025 subsequent to the Iodine acquisition. Indemnification of Directors and Officers We have entered into an indemnification agreement with each of our directors and executive officers. The indemnification agreements, together with our amended and restated bylaws, provide that we will jointly and severally indemnify each indemnitee to the fullest extent permitted by the DGCL from and against all loss and liability suffered and expenses, judgments, fines, and amounts paid in settlement actually and reasonably incurred by or on behalf of the indemnitee in connection with any threatened, pending, or completed action, suit, or proceeding. Additionally, we have agreed to advance to the indemnitee all out-of-pocket costs of any type or nature whatsoever incurred in connection therewith.”
Read it in the proxyopen_in_new
Related Persons Transaction Policy“Our Board has adopted a written policy on transactions with related persons, which we refer to as our “related person policy.” Our related person policy requires that all “related persons” (as defined in paragraph (a) of Item 404 of Regulation S-K) must promptly disclose to our Chief Legal Officer any “related person transaction” (defined as any transaction that is anticipated would be reportable by us under Item 404(a) of Regulation S-K in which we were or are to be a participant and the amount involved exceeds $120,000 and in which any related person had or will have a direct or indirect material interest) and all material facts with respect thereto. Our Chief Legal Officer will communicate that information to our Board or to a duly authorized committee thereof, who are responsible for applying the related person policy and procedures. Our related person policy provides that no related person transaction entered into following the completion of our initial public offering will be executed without the approval or ratification of our Board or a duly authorized committee thereof. It is our policy that any directors interested in a related person transaction must recuse themselves from any vote on a related person transaction in which they have an interest.”
Read it in the proxyopen_in_new
No longer reported 11 paragraphs of the proxy filed Apr 29, 2025 with nothing like them this year
Registration Rights Agreement“We are party to an amended and restated registration rights agreement, dated as of June 10, 2024, with EQT, CPPIB, Bain, and certain equity holders, including members of management.”
Read it in last year's proxyopen_in_new
Registration Rights Agreement“The amended and restated registration rights agreement contains provisions that entitle EQT, CPPIB, Bain, and the other stockholder parties thereto, including members of management, to certain rights to have their securities registered by us under the Securities Act. EQT is entitled to an unlimited number of “demand” registrations and CPPIB and Bain are each entitled to three “demand” registrations, subject to certain limitations. Certain stockholders are also entitled to customary “piggyback” registration rights. In addition, the amended and restated registration rights agreement provides that we will pay certain expenses of the stockholder parties relating to such registrations and indemnify them against certain liabilities which may arise under the Securities Act.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“We are party to the Stockholders Agreement, dated as of June 10, 2024, with EQT, CPPIB, Bain, and certain equity holders, including members of management.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“The Stockholders Agreement initially provided that our board of directors would consist of 10 members, however, effective as of April 10, 2025, the Stockholders Agreement was amended to provide that our board of directors could consist of up to 12 members. Pursuant to the Stockholders Agreement, EQT will have the right to nominate to our board of directors (i) two nominees for so long as EQT beneficially owns 25% or greater of our then-outstanding common stock, and (ii) one nominee for so long as EQT beneficially owns 5% or greater, but less than 25% of our then-outstanding common stock. CPPIB will have the right to nominate to our board of directors one nominee for so long as CPPIB beneficially owns 5% or greater of our then-outstanding common stock. Bain will have the right to nominate to our board of directors one nominee for so long as Bain beneficially owns 5% or greater of our then-outstanding common stock. EQT will have the right to designate the chairperson of our board of directors for so long as it beneficially owns at least 20% of our then-outstanding common stock, with the consent of CPPIB (not to be unreasonably withheld). For so long as CPPIB beneficially owns 10% or greater of our then-outstanding common stock, CPPIB will have the right to appoint one non-voting board observer, who will have the right to attend all meetings in a non-voting, observer capacity. In addition, our board of directors is divided into three classes and serve staggered, three year terms until the second annual meeting of stockholders after the date on which EQT, CPPIB, and Bain collectively own less than 15% in voting power of the then-outstanding power of the then-outstanding shares of stock of our Company entitled to vote generally in the election of directors, after which the board will no longer be divided into three classes. Furthermore, if any representatives of EQT serve on any boards or committees of our subsidiaries, CPPIB and Bain will have an equivalent right such that the board of directors of such subsidiary or committee thereof reflects, to the maximum extent possible, the composition of our board of directors and its committees as required under the Stockholders Agreement.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“Subject to applicable laws and stock exchange regulations, and subject to requisite independence requirements applicable to such committee, the Stockholders Agreement and our certificate of incorporation provide that for so long as EQT, CPPIB, and Bain collectively beneficially own 5% or greater of our then- outstanding common stock, (i) the Bain director nominee will be appointed to serve on the Audit, Compliance, & Risk Committee, (ii) the CPPIB director nominee and one EQT director nominee will be appointed to serve on the Talent & Compensation Committee, and (iii) the CPPIB director nominee and one EQT director nominee will be appointed to serve on the Nominating and Corporate Governance Committee.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“Pursuant to the Stockholders Agreement, we will include the EQT, CPPIB, and Bain nominees on the slate that is included in our proxy statement relating to the election of directors of the class to which such persons belong, subject to the ownership thresholds described above. In addition, pursuant to the Stockholders Agreement, EQT, CPPIB, and Bain will agree, severally and not jointly, with the Company to vote in favor of the Company slate that is included in our proxy statement.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“In the event that an EQT, CPPIB, or Bain nominee ceases to serve as a director for any reason (other than the failure of our stockholders to elect such individual as a director), EQT, CPPIB, or Bain, as applicable, will be entitled to appoint another nominee to fill the resulting vacancy.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“Affiliates of Bain and CPPIB are lenders under our First Lien Credit Facility. For the year ended December 31, 2024, the largest aggregate amount of principal outstanding that was owed to Bain under the First Lien Credit Facility was $32.4 million, which bore interest at a rate of 2.25% per annum above the SOFR rate, and the Company paid $15.2 million in principal and $3.9 million in interest. For the year ended December 31, 2023, the largest aggregate amount of principal outstanding that was owed to Bain under the First Lien Credit Facility was $47.5 million, which, as of December 31, 2023, bore interest at a rate of 4.11% per annum above the SOFR rate, and the Company paid $0.8 million in principal and $4.9 million in interest. For the year ended December 31, 2022, the largest aggregate amount of principal outstanding that was owed to Bain under the First Lien Credit Facility was $60.2 million, which, as of December 31, 2022, bore interest at a rate of 4.00% per annum above the LIBOR rate, and the Company paid $0.6 million in principal and $3.5 million in interest. As of December 31, 2024, $32.4 million in aggregate principal amount of term loans under the First Lien Credit Facility that was owed to Bain remained outstanding.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“For the year ended December 31, 2024, the largest aggregate amount of principal outstanding that was owed to CPPIB under the First Lien Credit Facility was $17.7 million, which bore interest at a rate of 2.25% per annum above the SOFR rate, and the Company paid $14.6 million in principal and $0.6 million in interest. Following the refinancing of the First Lien Credit Facility in February 2024, CPPIB no longer holds any of the loans under the First Lien Credit Facility. For the year ended December 31, 2023, the largest aggregate amount of principal outstanding that was owed to CPPIB under the First Lien Credit Facility was $17.7 million, which, as of December 31, 2023, bore interest at a rate of 4.11% per annum above the SOFR rate, and the Company paid $0.4 million in principal and $2.7 million in interest. For the year ended December 31, 2022, the largest aggregate amount of principal outstanding that was owed to CPPIB under the First Lien Credit Facility was $49.0 million, which, as of December 31, 2022, bore interest at a rate of 4.00% per annum above the LIBOR rate, and the Company paid $0.4 million in principal and $2.8 million in interest. As of December 31, 2024, $3.2 million in aggregate principal amount of term loans under the First Lien Credit Facility that was owed to CPPIB remained outstanding.”
Read it in last year's proxyopen_in_new
Stockholders Agreement“Affiliates of Bain received $28.8 million from the proceeds of our IPO that were used to repay the First Lien Credit Facility.”
Read it in last year's proxyopen_in_new
Other Related Party Transactions“We have entered into an operating lease agreement with Parkway Properties, under which we lease office space in Houston, Texas from Parkway Properties. CPPIB beneficially owns greater than 10% of Parkway Properties. We paid approximately $0.2 million, $0.3 million, and $0.2 million to Parkway Properties for the years ended December 31, 2024, 2023, and 2022, respectively.”
Read it in last year's proxyopen_in_new
The whole section
As filed
4 paragraphs quoted as filed
Other Related Party Transactions“We have entered into commercial transactions in the ordinary course of business with companies in which Bain and CPPIB have ownership interests:”
Read it in the proxyopen_in_new
Other Related Party Transactions“+Aveanna Healthcare, LLC, Surgery Partners Holdings LLC, Athena Therapy, US Renal Care, AccentCare, and Definitive Healthcare are our clients to whom we provide software solutions. Bain beneficially owns greater than 10% of each of Aveanna Healthcare, LLC, Surgery Partners Holdings LLC, Athena Therapy, and US Renal Care. We received approximately $0.4 million from Aveanna Healthcare, LLC for the year ended December 31, 2025. We received approximately $1.3 million from Surgery Partners Holdings LLC for the year ended December 31, 2025. We received approximately $0.1 million from Athena Therapy for the year ended December 31, 2025. We received approximately $0.8 million from US Renal Care for the year ended December 31, 2025. After the Iodine acquisition on October 1, 2025, Advent has an ownership interest in us and beneficially owns greater than 10% of AccentCare and Definitive Healthcare. We received approximately $0.4 million from AccentCare for the year ended December 31, 2025 subsequent to the Iodine acquisition. We received approximately $0.4 million from Definitive Healthcare for the year ended December 31, 2025 subsequent to the Iodine acquisition.”
Read it in the proxyopen_in_new
Other Related Party Transactions“+Rocket Software, Fidelity Information Services, CitrusTech, and Definitive Healthcare are vendors that provide us with software solutions. Bain beneficially owns greater than 10% of each of Rocket Software, Fidelity Information Services, and Citrus Tech. We paid approximately $0.4 million to Rocket Software for the year ended December 31, 2025. We paid approximately $1.9 million to Fidelity Information Services for the year ended December 31, 2025. We paid approximately $0.3 million to Citrus Tech for the year ended December 31, 2025. After the Iodine acquisition on October 1, 2025, Advent has an ownership interest in us and beneficially owns greater than 10% of Definitive Healthcare. We paid approximately $0.1 million to Definitive Healthcare for the year ended December 31, 2025 subsequent to the Iodine acquisition. Indemnification of Directors and Officers We have entered into an indemnification agreement with each of our directors and executive officers. The indemnification agreements, together with our amended and restated bylaws, provide that we will jointly and severally indemnify each indemnitee to the fullest extent permitted by the DGCL from and against all loss and liability suffered and expenses, judgments, fines, and amounts paid in settlement actually and reasonably incurred by or on behalf of the indemnitee in connection with any threatened, pending, or completed action, suit, or proceeding. Additionally, we have agreed to advance to the indemnitee all out-of-pocket costs of any type or nature whatsoever incurred in connection therewith.”
Read it in the proxyopen_in_new
Related Persons Transaction Policy“Our Board has adopted a written policy on transactions with related persons, which we refer to as our “related person policy.” Our related person policy requires that all “related persons” (as defined in paragraph (a) of Item 404 of Regulation S-K) must promptly disclose to our Chief Legal Officer any “related person transaction” (defined as any transaction that is anticipated would be reportable by us under Item 404(a) of Regulation S-K in which we were or are to be a participant and the amount involved exceeds $120,000 and in which any related person had or will have a direct or indirect material interest) and all material facts with respect thereto. Our Chief Legal Officer will communicate that information to our Board or to a duly authorized committee thereof, who are responsible for applying the related person policy and procedures. Our related person policy provides that no related person transaction entered into following the completion of our initial public offering will be executed without the approval or ratification of our Board or a duly authorized committee thereof. It is our policy that any directors interested in a related person transaction must recuse themselves from any vote on a related person transaction in which they have an interest.”
Read it in the proxyopen_in_new
Paragraphs are compared by their words, not read by AI: one counts as new when no paragraph last year shares half of its words, or when it names a person or company last year's section did not. A deal reported again with a new amount is not new. Always check the filing. Open the proxy ↗ · Last year's proxy ↗
Sources
The related-party section (Item 404) of the latest annual proxy statement (DEF 14A), against last year's, compared by their words.
Also
CEO pay: the same proxy's pay versus performance table.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/WAY/export.csv") into a cell.